相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2019 ESC Guidelines for the dignosis and management of acute pulmonary embolism development Toed in colaboration with the European Respiratory Society (ERS)
Stavros Konstantinides et al.
EUROPEAN HEART JOURNAL (2020)
Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study
Hisham Badreldin
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study
Frederikus A. Klok et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF
Jean-Pierre Bassand et al.
EUROPEAN HEART JOURNAL (2016)
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study
Marjolein P. A. Brekelmans et al.
Lancet Haematology (2016)
Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
Isabelle Mahe et al.
PLOS ONE (2015)
Safe-Dose Thrombolysis Plus Rivaroxaban for Moderate and Severe Pulmonary Embolism: Drip, Drug, and Discharge
Mohsen Sharifi et al.
CLINICAL CARDIOLOGY (2014)
Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism
Guy Meyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis
Antonio Gomez-Outes et al.
THROMBOSIS RESEARCH (2014)
Long-term prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate- to high-risk pulmonary embolism
Nicolas Meneveau et al.
EUROPEAN HEART JOURNAL (2013)
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Evaluation of Bleeding Risk in Patients Exposed to Therapeutic Unfractionated or Low-Molecular-Weight Heparin: A Cohort Study in the Context of a Quality Improvement Initiative
Benoit Cossette et al.
ANNALS OF PHARMACOTHERAPY (2010)
Simplification of the Pulmonary Embolism Severity Index for Prognostication in Patients With Acute Symptomatic Pulmonary Embolism
David Jimenez et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Oral Rivaroxaban for Symptomatic Venous Thromboembolism.
Rupert Bauersachs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Improving adjunctive treatment in pulmonary embolism and fibrinolytic therapy. The role of enoxaparin and weight-adjusted unfractionated heparin
Carlos Jerjes-Sanchez et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2009)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement Guidelines for Reporting Observational Studies
Erik von Elm et al.
EPIDEMIOLOGY (2007)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
A modified Poisson regression approach to prospective studies with binary data
GY Zou
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
分享论文
